Business · 14/06/2017Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Collection of Information for Prescription Drug Promotion Disclosures
Summary
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to prescription drug promotion disclosures, as required by the Paperwork Reduction Act of 1995, and will accept comments for 60 days.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →